Cancer immunology research | 2021
Abstract IA08: What are some different ways to evaluate immunotherapy combinations?
Abstract
This talk will focus on new ways to consider clinical trials testing combinations of immunotherapy agents. Lessons learned from explorations of the combination of PD-1 + CTLA-4 blockade will be shared. Specifically, we will review data related to the concept of treatment free survival as well as highlight recent data using an adaptive/individualized approach to de-escalate combination immunotherapy in patients with advanced melanoma. Citation Format: Michael Postow. What are some different ways to evaluate immunotherapy combinations? [abstract]. In: Abstracts: AACR Virtual Special Conference: Tumor Immunology and Immunotherapy; 2020 Oct 19-20. Philadelphia (PA): AACR; Cancer Immunol Res 2021;9(2 Suppl):Abstract nr IA08.